Structure-based design of imidazo[1,2-a] pyrazine derivatives as selective inhibitors of Aurora-A kinase in cells

被引:28
作者
Bouloc, Nathalie [1 ]
Large, Jonathan M. [1 ]
Kosmopoulou, Magda [2 ]
Sun, Chongbo [1 ]
Faisal, Amir [1 ]
Matteucci, Mizio [1 ]
Reynisson, Johannes [1 ]
Brown, Nathan [1 ]
Atrash, Butrus [1 ]
Blagg, Julian [1 ]
McDonald, Edward [1 ]
Linardopoulos, Spiros [1 ,3 ]
Bayliss, Richard [2 ]
Bavetsias, Vassilios [1 ]
机构
[1] Inst Canc Res, Canc Res UK Canc Therapeut Unit, Sutton SM2 5NG, Surrey, England
[2] Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, London SW3 6JB, England
[3] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England
关键词
Aurora-A; Selectivity; Kinases; SMALL-MOLECULE INHIBITOR; CRYSTAL-STRUCTURE; DISCOVERY; POTENT; IDENTIFICATION; MLN8054; OVEREXPRESSION; EXPRESSION; CARCINOMA;
D O I
10.1016/j.bmcl.2010.08.091
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Co-crystallisation of the imidazo[ 1,2-a] pyrazine derivative 15 (3-chloro-N-(4-morpholinophenyl)-6-( pyridin-3-yl)imidazo[1,2-a]pyrazin-8-amine) with Aurora-A provided an insight into the interactions of this class of compound with Aurora kinases. This led to the design and synthesis of potent Aurora-A inhibitors demonstrating up to 70-fold selectivity in cell-based Aurora kinase pharmacodynamic biomarker assays. (c) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5988 / 5993
页数:6
相关论文
共 37 条
[1]  
[Anonymous], 2008, Comprehensive Heterocyclic Chemistry III
[2]   High expression of Aurora-B/Aurora and Ipl1-like midbody-associated protein (AIM-1) in astrocytomas [J].
Araki, K ;
Nozaki, K ;
Ueba, T ;
Tatsuka, M ;
Hashimoto, N .
JOURNAL OF NEURO-ONCOLOGY, 2004, 67 (1-2) :53-64
[3]  
BAVETSIAS V, 2007, Patent No. 2007072017
[4]   Imidazo[4,5-b]pyridine Derivatives As Inhibitors of Aurora Kinases: Lead Optimization Studies toward the Identification of an Orally Bioavailable Preclinical Development Candidates [J].
Bavetsias, Vassilios ;
Large, Jonathan M. ;
Sun, Chongbo ;
Bouloc, Nathalie ;
Kosmopoulou, Magda ;
Matteucci, Mizio ;
Wilsher, Nicola E. ;
Martins, Vanessa ;
Reynisson, Johannes ;
Atrash, Butrus ;
Faisal, Amir ;
Urban, Frederique ;
Valenti, Melanie ;
Brandon, Alexis de Haven ;
Box, Gary ;
Raynaud, Florence I. ;
Workman, Paul ;
Eccles, Suzanne A. ;
Bayliss, Richard ;
Blagg, Julian ;
Linardopoulos, Spiros ;
McDonald, Edward .
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (14) :5213-5228
[5]   A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers [J].
Bischoff, JR ;
Anderson, L ;
Zhu, YF ;
Mossie, K ;
Ng, L ;
Souza, B ;
Schryver, B ;
Flanagan, P ;
Clairvoyant, F ;
Ginther, C ;
Chan, CSM ;
Novotny, M ;
Slamon, DJ ;
Plowman, GD .
EMBO JOURNAL, 1998, 17 (11) :3052-3065
[6]   SYNTHESIS AND ANTIBRONCHOSPASTIC ACTIVITY OF 8-ALKOXY AND 8-(ALKYLAMINO)IMIDAZO[1,2-A]PYRAZINES [J].
BONNET, PA ;
MICHEL, A ;
LAURENT, F ;
SABLAYROLLES, C ;
RECHENCQ, E ;
MANI, JC ;
BOUCARD, M ;
CHAPAT, JP .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (18) :3353-3358
[7]   PdCl2-catalyzed reduction of organic halides by triethylsilane [J].
Boukherroub, R ;
Chatgilialoglu, C ;
Manuel, G .
ORGANOMETALLICS, 1996, 15 (05) :1508-1510
[8]   HETEROCYCLES .167. TELE-SUBSTITUTION AND OTHER TRANSFORMATIONS OF IMIDAZO[1,2-A]-AND S-TRIAZOLO[4,3-A]PYRAZINES [J].
BRADAC, J ;
FUREK, Z ;
JANEZIC, D ;
MOLAN, S ;
SMERKOLJ, I ;
STANOVNIK, B ;
TISLER, M ;
VERCEK, B .
JOURNAL OF ORGANIC CHEMISTRY, 1977, 42 (26) :4197-4201
[9]   The cellular geography of aurora kinases [J].
Carmena, M ;
Earnshaw, WC .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2003, 4 (11) :842-854
[10]   PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer [J].
Carpinelli, Patrizia ;
Ceruti, Roberta ;
Giorgini, Maria Laura ;
Cappella, Paolo ;
Gianellini, Laura ;
Croci, Valter ;
Degrassi, Anna ;
Texido, Gernma ;
Rocchetti, Maurizio ;
Vianello, Paola ;
Rusconi, Luisa ;
Storici, Paola ;
Zugnoni, Paola ;
Arrigoni, Claudio ;
Soncini, Chiara ;
Alli, Cristina ;
Patton, Veronica ;
Marsiglio, Aurelio ;
Ballinari, Dario ;
Pesenti, Enrico ;
Fancelli, Daniele ;
Moll, Jurgen .
MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) :3158-3168